23.6 C
Sunday, November 1, 2020

When we get a coronavirus vaccine, thank intellectual property rights

Good news in the fight against the novel coronavirus is finally starting to build.

Now in trials, AstraZeneca believes it will be able to seek regulatory approval for its vaccine by the end of the year. Also in trials, BioNTech believes the vaccine it is producing with Pfizer could be ready for administration by December. Johnson & Johnson has begun human trials of its vaccine and anticipates phase 3 trials by the end of September.

There’s good news on treatments, too, such as remdesivir, which recent data from Gilead Sciences shows can reduce the death rate for severely ill patients by an impressive 62%. AstraZeneca recently announced that it has begun testing an antibody-based cocktail for the prevention and treatment of COVID-19, joining an approach being followed by Eli Lilly, Roche, and others.

It feels as though, just as we all hoped, medical science is coming to the rescue.

However, all this momentum rests on the genius of the protection of intellectual property, which the United States owes in part to the framers of the Constitution and our historically strong advocacy of IP protections among our trading partners. Thanks to our IP protections and market-based pricing, 70% of new medicines are launched in the U.S., and our labs account for 80% of all medicines in the global development pipeline.

Emerging threats to this IP regime, such as compulsory licensing, have the potential to derail the very biopharmaceutical research and development that we desperately need right now.

It costs approximately $2.6 billion to develop one new medicine and normally takes 10 to 15 years to bring it to market. Even after investing all of this time and money, less than 12% of potential new therapies receive approval from the Food and Drug Administration. To take on this tremendous risk, drug companies and capital markets need to feel secure in that they can recoup research and development costs. IP protections such as patent rights and exclusive licenses provide some certainty.

For example, remdesivir was initially developed to treat Ebola, but it proved ineffective in late-stage testing. Gilead retained its ownership of the underlying IP, though, and the unrealized potential of this treatment helped propel Gilead to launch into testing in March of this year. Now, it is saving lives from COVID-19.

But a compulsory license allows another company to copy and sell a patented product without the consent of the patent owner. Compulsory licensing by its nature erodes the certainty IP patent rights are intended to shore up in the first place. One can imagine a circumstance in which such an extreme step is necessary, such as refusing to produce a therapy or vaccine in a time of urgent need. It isn’t credible to claim that sort of circumstance is happening now. For example, Johnson & Johnson has recently announced a $480 million deal with Emergent BioSolutions to get vaccine doses produced as quickly as possible, and novel partnerships are popping up across the industry.

Nonetheless, several countries are taking steps toward compulsory licensing, claiming that doing so will increase access to new therapies. Israel has already granted a compulsory license for an HIV medication based on the possibility that it may be able to treat coronavirus patients. Chile and Ecuador have both passed resolutions supporting compulsory licensing.

Even in the U.S., some lawmakers, anti-IP organizations, and far-Left activists are calling for the manipulation of U.S. law to strip the exclusive licenses and patent rights from therapy creators. The law they reference, the Bayh-Dole Act, only allows the government to act under very limited and specified circumstances, such as if a firm actively refuses to mass-produce a medicine or re-license. It’s tough to envision this happening since doing this would be contrary to the financial interests of everyone involved.

Thankfully, accessing vaccines during public health emergencies has not been an issue. During the Zika outbreak, for example, the National Institutes of Health issued an exclusive license to PaxVax to produce a vaccine. In response to the ensuing criticism, our now-familiar Dr. Anthony Fauci said, “I have not seen in my experience situations in which we were involved in the development of a vaccine, particularly for low- and middle-income countries that really needed it, where the pharmaceutical companies priced it out of their reach.”

Companies working on vaccines for COVID-19 have made promises that this will remain the case for the coronavirus. Johnson & Johnson has promised 1 billion doses on a not-for-profit basis, and Gilead is donating 1.5 million doses of remdesivir for compassionate use.

It’s good to be able to count on medicine coming to the rescue, but we shouldn’t take it for granted. Granting compulsory licenses will slow drug development for the coronavirus and cripple us in the fight against the next pandemic. If we start telling companies that they’re not going to get to keep the resulting IP, they’ll stop investing in the development and production of these medicines. If we destroy this system, it won’t be here the next time we need it.

Christopher Butler is the executive director of Americans for Tax Reform.

Read More at Washingtonexaminer

Latest news

What’s Happened To Bitcoin Since Its Whitepaper Appeared 12 Years Ago?

Authored by Robert Stevens via Decrypt.io,In briefOn October 31, 2008, Satoshi Nakamoto published the Bitcoin whitepaper. Since then, Bitcoin's journey has taken in highs and...

Large US Early Voting Surge as Trump, Biden Make Late Push

A record 90 million Americans have voted early in the U.S. presidential election, data on Saturday showed, as President Donald Trump and his Democratic...

Trump edges out Biden in Iowa in gold-standard poll

President Trump has pulled ahead of Democratic presidential nominee Joe Biden in Iowa three...

Third grand juror in Breonna Taylor case wants to speak out

A third grand juror in the Breonna Taylor case plans to speak out about the controversial deliberations that cleared three Louisville cops of any...

Related news

De Blasio, Cuomo & Co. couldn’t be bothered to prevent early-voting mess

Mayor de Blasio and Gov. Cuomo’s fury over the hours-long early-voting lines would be totally righteous — except that these problems were entirely foreseeable,...

LA County Continues War On California Megachurch Over COVID-19

Los Angeles County is threatening to continue sending health investigators and doctors from its Outbreak Management Department to John MacArthur’s Grace Community Church during...

UK Prime Minister Boris Johnson Announces Month-Long Lockdown

British Prime Minister Boris Johnson announced that England would undergo a second nationwide lockdown through the start of December, ahead of the winter holidays. “Now...

Watch These Nontraditional Horror Movies For A Spooky Halloween

Happy Halloween! With most of the country still predominately shut down, it’s likely that costume parties and trick-or-treating will not be available for most...

Biden will lead the Democratic Party’s war on our institutions

For all the talk that President Trump’s reelection would destroy the country's institutions, Joe...

Trending News

White House Blocks CDC ‘No Sail’ Order

The Centers for Disease...

Rasmussen poll says 46% of black voters approve of President Trump

A daily tracking poll of President Donald Trump's job approval released Friday showed an eye-popping surge in approval for Trump among black voters. According...

High Potency Marijuana, Psychosis, and Suicide: Johnny Stack’s Story

DENVER—It’s a grief that’s unimaginable. Deep, raw, and ever present. Laura and John Stack are still reeling over the loss of their son to...

WATCH: BLM Protesters Target Jews in Philadelphia While Yelling ‘Synagogue of Satan’

Rioters in Philadelphia, Pennsylvania, targeted a group of Jews at protests Tuesday evening against the police shooting of an armed black man, calling them...

Twitter suspends Border Patrol chief’s account for ‘hateful conduct’ over praising border wall

Twitter suspended the account belonging to U.S. Customs and Border Protection Commissioner Mark Morgan...

Former never-Trumper James Lindsay on why he just CAN’T vote for Joe Biden

This is a moment "Cynical Theories" author James Lindsay probably hoped would never come. The liberal mathematician and host of the "New Discourses Podcast"...

UPS Locates Joe Biden-Related Documents That Tucker Carlson Said Were Lost

Delivery giant UPS confirmed Thursday it found a lost trove of documents that Fox News’ Tucker Carlson said would provide revelations in the ever-growing...

Joe Biden Boasts Of ‘Most Extensive’ Voter Fraud ‘In The History Of American Politics’

Democratic Presidential Nominee Joe Biden recently bragged that Democrats have created the “most extensive and inclusive voter fraud organization in the history of American...